Align Technology reported $821.72M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
3M USD 5.03B 141M Sep/2026
Align Technology USD 821.72M 43.15M Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Bruker USD 790.5M 21.6M Sep/2026
Cardinal Health USD -3.03B 65.88B Sep/2026
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
CVS Health USD 104.83B 5.47B Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.36B 4M Sep/2026
Dexcom USD 990.1M 53.5M Jun/2026
Henry Schein USD 3.27B 8M Sep/2026
Idexx Laboratories USD 811.89M 20.87M Sep/2026
Insulet USD 652.2M 19.8M Sep/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
McKesson USD 109.27B 5.31B Sep/2026
Mettler Toledo International USD 77.66M 662.11M Sep/2026
Revvity USD 604.27M 719K Sep/2026
Solventum Corp USD 4.81B 5M Sep/2026
Stryker USD 4.8B 118M Jun/2026
Teleflex USD 3.49B 589.18M Sep/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Veeva Systems USD 652.94M 43.11M Jun/2026
Waters USD 527M 592M Jun/2026
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026
Zoetis USD 3.3B 155M Sep/2026